Industry Insights
Circulating tumor cells (CTC) market is expected to grow over the
forecast period owing to the increasing prevalence of cancer and growing
population. The other growth drivers of this market are introduction of
technological advancements such as hybrid method of synthesis of
peptides, lifestyle induced diseases such as obesity & diabetes,
sophisticated healthcare infrastructure, increasing population and
awareness. These factors are expected to drive the market over the
forecast period.
Cancer is disease caused by abnormal cell growth and has possibility
to spread to other parts of the body too. The symptoms or sign are such
as change in bowel movements, unexplained weight loss, prolonged cough,
abnormal bleeding, and new lump. For deciding the procedure of treatment
cancer prognosis plays a vital role. Under liquid biopsy, biomarker is
preferred more than other tissue biopsy procedures, as it follows
minimally invasive procedure.
Browse Detail Report With TOC @ http://www.hexaresearch.com/research-report/circulating-tumor-cells-industry/
Globally, this market in 2013 was valued at $ 15 million and over
the forecast period it will be growing at a CAGR of over 27%. By the end
of 2020, it is expected that market value will touch the figure of 22
million. Increasing incidences of cancer induced lifestyle habits such
as continuous exposure to UV, lack of exercise, dietary habits,
excessive alcohol consumption, smoking and chewing tobacco. Complex
isolation of tumor cells is anticipated to restraining the market over
the upcoming five years.
Technology Insights
CTC market is segmented on the basis of technology into tumor cell
enrichment & detection, molecular, optical, and immunological and
immunomagnetic, centrifugation, filtration. Among these, tumor cell
enrichment & detection held the largest market share in 2013, owing
to relatively friendly operation, faster outcome availability, easy
sample collection, and high accuracy level. Tumor cell enrichment &
detection technology market over the forecast period is anticipated to
rise at a CAGR of 27%. Over the upcoming five years immunological &
immunomagnetic technology market will witness fastest CAGR, owing to its
operation with all genome sequencing and its effective analysis along
with lesser blood sample. Additionally, R & D t is anticipated to
boost the market over the forecast period.
Application Insights
CTC market is segmented on the basis of application into breast
cancer, colorectal cancer, and prostate cancer. Among these, breast
cancer held the largest market share in 2013 due to generation of
circulatory tumor cells from small primary tumors and higher frequency
of malignancy. Metastasis in incidental vital organs is the main reason
for cancer fatality. As per the report publish by WHO in 2013, it says
that 8.5 million death occurs due to cancer, out of that 9.0% is liver
constituted, 8.5% is constituted by breast cancer, and 8.4% is
constituted by colorectal cancer.
Request A Sample copy of This Report @ http://www.hexaresearch.com/sample/184
Regional Insights
Geographically, the CTC market is studied with respect to four
regions such as Asia Pacific, Europe, North America, and RoW. Among
these, North America is dominating the whole market in 2013, as it has
presence of technologically updated systems, strong research &
development, various government initiatives & programs and high
patient awareness levels in this region. The growing economies in Asia
Pacific such as India and China region are expected to witness lucrative
growth over the forecast period owing to the rising healthcare
expenditure, and awareness about the hospital acquired infection.
Competitive Insights
The major market players in the circulating tumor cells market are
Advanced Cell Diagnostics Inc., Veridex, LLC., Vitatex Inc., AdnaGen AG,
AVIVA BioSciences Corporation and Silicon Biosystems.
Browse Full Report @ http://www.hexaresearch.com/research-report/circulating-tumor-cells-industry/
About Us:
Hexa Research is a market research and consulting organization,
offering industry reports, custom research and consulting services to a
host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients
obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website - http://www.hexaresearch.com/
Visit our Blog: http://hexaresearchinc.blogspot.com/
No comments:
Post a Comment